autologous cultured chondrocytes on porcine collagen membrane (Maci)
autologous cultured chondrocytes on porcine collagen membrane is an FDA-licensed reference biologic from Vericel Corporation. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2016
Reference approved
Reference product
Maci autologous cultured chondrocytes on porcine collagen membrane
Vericel Corporation
- Approved
- Dec 13, 2016
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for autologous cultured chondrocytes on porcine collagen membrane, in chronological order.
Reference approval
Approval date of the reference autologous cultured chondrocytes on porcine collagen membrane product.
9 yr 7 mo ago
Frequently asked questions
Are there biosimilars approved for autologous cultured chondrocytes on porcine collagen membrane (Maci)?
No 351(k) biosimilars or interchangeable biosimilars referencing autologous cultured chondrocytes on porcine collagen membrane are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.